Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Opinion: Ironworkers President on ‘The Link Between Innovation and Job Creation’; Calls on Congress to Protect Innovation

1/27/2016

0 Comments

 
Washington, DC ― Eric Dean, general president of the Ironworkers International and chairman of the Pharmaceutical Industry Labor-Management Association (PILMA), writes in The Hill:
 
“As the general president of the Ironworkers union, representing 130,000 skilled craft workers in North America, one of my most important responsibilities is to help protect the jobs of highly skilled workers.
 
“The men and women who are members of my union, Ironworkers International, have undergone rigorous apprenticeship training. They have dedicated long nights, days and weekends to hone their craft and earn the right to return to the job site the next day. 
 
“The building trades are committed to equipping their members with cutting-edge skill sets to be the best. They have over 1600 training facilities located in every state in the U.S. and train thousands of members a year, using zero taxpayer dollars.
​“The benefit from undergoing extensive training should be good paying jobs with healthcare and pension benefits, all earned by helping to build America’s infrastructure and meeting the construction needs of American business.
 
“There is one industry in particular that depends on our meticulous skill set for their own survival. The biopharmaceutical industry knows that state-of-the-art facilities are essential to discovering life-saving medicines and therapies.  For each new drug developed, facilities must be wiped clean, whole systems must be replaced while guaranteeing no cross contamination.
 
“This industry relies on the building construction trades unions to build, maintain and retrofit these facilities. In order to meet the rigorous standards of biopharmaceutical manufacturers, our training centers align curriculum to the needs of the industry.  The development of new life saving drugs depends on this key relationship.
 
“At a time when the regulatory environment surrounding medicines is continually in flux, building and retrofitting biopharmaceutical manufacturing and research facilities must be flawlessly executed on schedule. Our skill, reliability and professionalism create a foundation of certainty that the job will be done on time, on budget and right the first time.
 
“At the same time, while these companies rely on a skilled craft workforce to help them construct the facilities where they research and discover new medicines, they also rely on an intellectual property regime that will provide continuity and certainty for these life-saving medicines.  Our patent system ensures that products developed by companies here in the United States will not be pirated and sold illegally.
 
“As chairman of the Pharmaceutical Industry Labor-Management Association (PILMA), a coalition of labor unions and companies in the biopharmaceutical industry dedicated to innovation and growing the economy, I cannot stress enough the importance of strong intellectual property protections to economic growth.
 
“The logic is plain and simple: Patents are surrounded by current jobs, and future jobs. Strong IP protections help create a stable environment for businesses to invest, for innovation to thrive and for new development. Each new facility presents an opportunity for our members to earn a living, support their family and maintain stability in the middle class.
 
“The United States is the most innovative country in the world and we must keep it that way. The more a country invests in its research and development, the stronger the economy. 
 
“On average it takes 10-15 years to develop a new drug, costing $2.6 billion, and most never even make it to market.  The U.S. must ensure that the investment of time, money and human capital will be protected if biopharmaceutical companies are successful and have the opportunity to earn a return.
 
“Our members take great pride in their work. The satisfaction of building a structure that will be a permanent part of a city’s skyline is unmatched only by the fulfillment of building a facility that will cure diseases and saves lives.
 
“Patents are the foundation of innovation. It is what biopharmaceutical companies are built on. Labor and industry have fulfilled their commitment to working together. Now it’s time for the United States Congress to renew its commitment to protecting innovation and the livelihoods of the best trained workers in the world.”
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Home   Coalition   News   Resources   Events   Join Us
Picture
Innovation New Jersey Coalition
10 West Lafayette Street
Trenton, NJ 08608-2002
609-858-9507